Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Enzyme inactivation by chemical treatment
Patent
1995-04-28
1997-12-02
Lilling, Herbert J.
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Enzyme inactivation by chemical treatment
435180, 435183, 435213, 514184, C12N 999, C12N 1108, C12N 976
Patent
active
056935153
ABSTRACT:
Serine protease inhibitors are provided comprising compounds having a P site binding moiety and a divalent cation(s) chelating moiety which are pre-prepared as divalent cation(s) complexes or combined with the serine protease in the presence of divalent cation(s). The compounds are shown to have high inhibitory activity when complexed to divalent cation(s) and find use in various processes associated with serine protease isolation and inhibition.
REFERENCES:
patent: 3911111 (1975-10-01), Sawada et al.
patent: 4847202 (1989-07-01), Powers
patent: 4935493 (1990-06-01), Bachovchin et al.
patent: 4940723 (1990-07-01), Tidwell et al.
patent: 4980287 (1990-12-01), Kobuko et al.
patent: 5324648 (1994-06-01), Powers et al.
patent: 5498610 (1996-03-01), Maccamo et al.
patent: 5510333 (1996-04-01), Angelastro et al.
patent: 5550139 (1996-08-01), Grouta
Ishikawa "A6R Biol Chem " vol. 35 No. 2 pp. 158-162 (1971).
Chem ABS 74: 71950Y (1971) Ishikawa.
Higaki et al., Regulation Of Serine Protease Activity By An Engineered Metal Switch (1990) Biochemistry, 29:8582-8586.
Tidwell et al., Diarylamidine Derivatives With One Or Both Of The Aryl Moieties Consisting Of An Indole Or Indole-Like Ring. Inhibitors Of Arginine-Specific Esteroproteases (1978) Journal of Medicinal Chemistry, vol. 21, No. 7:613-623.
Brothers II et al., Catalytic Activity Of The Serine Proteases .alpha.-Lytic Protease Tagged At The Active Site With A (Terpyridine)Platinum(II) Chromophore (1990) Biochemistry, 29:7468-7474.
Kang, Human Neutrophil Elastase: Rapid Purification, Metal Binding Stoichiometry And Modulation Of The Activity By Chelating Agents (1988) Korian J. of Pharmacology, vol. 24, No. 1:111-123.
Kelly et al., Interaction Between Non-Classical .beta.-Lactam Compounds And The Zn.sup.2+ -Containing G And Serine R61 and R39 D-Alandyl-Alanine Peptidases (1981) Biochem. J., 199:129-136.
Almenoff et al., Identification Of A Thermolysin-Like Metalloendopeptidase In Serum: Activity In Normal Subjects And In Patients With Sarcoidosis (1984) J. Lab and Clinical Medicine, vol. 103, No. 3:420-431.
Lombardy et al., "Synthesis and DNA Interactions of Benzimidazole Dications Which Have Activity Against Opportunistic Infections," J. Med. Chem (1996), 39:1452-1462.
Fairley et al., "Structure, DNA Minor Groove Binding, and Base Pair Specificity of Alkyl-and Aryl-Linked Bis(amidinobenzimidazoles) and Bis(amidinoindoles)," J. Med. Chem. (1993), 36:1746-1753.
Clark James M.
Jenkins Thomas E.
Katz Bradley A.
Stroud Robert M.
Arris Pharmaceutical Corporation
Lilling Herbert J.
Montgomery Wayne W.
Rowland Bertram I.
LandOfFree
Metal complexed serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metal complexed serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metal complexed serine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-800529